# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often com...
The Attorney General of New York, Letitia James, has called on the FDA to address safety risks associated with the widely used ...
Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of aware...
HADLIMA is an FDA-approved biosimilar to HUMIRA for the treatment of specific autoimmune or autoinflammatory conditions such as...
Organon exceeds Q4 2023 revenue expectations, reaching $1.6 billion. Women's Health thrives with 7% revenue increase, drive...
Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings.
U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday.